# Topical Multiple Ascending Dose Study for PF-06423264

> **NCT02778477** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 65 (actual)

## Conditions studied

- Normal Healthy

## Interventions

- **DRUG:** PF-06423264
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02778477
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-23
- **Primary completion:** 2017-05-23
- **Final completion:** 2017-05-23
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Preliminary analysis of accrued data failed to indicate any meaningful pharmacodynamic response.
- **Last updated:** 2017-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778477, "Topical Multiple Ascending Dose Study for PF-06423264". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02778477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*